Aviwell, a deep tech animal nutrition company headquartered in Toulouse, has successfully concluded an €11 million Series A financing round, marking a major milestone in its growth journey.
The round welcomed three new investors – Blue Revolution Fund, Blast.Club and SWEN Capital Partners – who join existing shareholders Elaia and MFS Investment Management, both of whom also participated.
The new capital will support Aviwell’s next phase of expansion as it scales its AI-driven microbiome discovery and development platform, Aneto, and advances native, nature-based biological solutions for global agri-food markets.
Initial commercial focus will be on poultry and aquaculture, two sectors facing mounting pressure to improve productivity while reducing antibiotic use and environmental impact.
“With Aneto, we translate microbiome complexity into practical, scalable solutions for producers,” said Mouli Ramani, president and chief executive of Aviwell.
“With the support of our new investors, we will accelerate development in poultry and aquaculture and expand our platform and product pipeline.”
Aviwell’s technology is built on decades of research led by co-founder Prof. Rémy Burcelin, which demonstrated that naturally occurring bacterial ecologies administered early in life can have durable effects on animal growth, health and resilience.
The Aneto platform combines advanced microbiota analysis with artificial intelligence and machine learning to identify precise molecular modes of action and design tailored bacterial communities.
This approach significantly shortens research and development timelines, lowers costs and speeds up time to market, says Aviwell.
